Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

16260 Ventura Blvd., Suite 140
Encino, CA 91436
Phone: 818-528-7776

November 17, 2019 by Alan Khadavi

Etokimab, anti IL-33 for Food Allergy

Etokimab is an antibody that inhibits IL-33.  IL-33 is a pro-inflammatory cytokine that is a central mediator of allergy diseases (i.e. food allergies).  By blocking IL-33, etokimab prevents the downstream inflammation that occurs with allergy diseases.

Etokimab is currently being studied for the treatment of atopic dermatitis and asthma by the pharmaceutical company AnaptysBio.

The results of the trial for eczema and asthma have been disappointing to date, but a recent small study explored Etokimab’s role in the treatment of food allergy, in this case peanut allergy.  A study was done with participants who had peanut allergy and they received an injection of Etokimab.  Nearly 3/4 of participants who received the injection were able to eat a modest amount of peanut 2 weeks after the shot. Zero of the patients who received a placebo were able to eat peanut.  Since Etokimab doesn’t particularly treat peanut specifically but overall allergies, there is a potential it could treat any food allergies such as tree nuts and shellfish.

This was a very small study and more studies need to be done. It still has not been determined at what frequency Etokimab would need to be given to protect against food allergies although researchers have been looking at a monthly treatment.  This most likely would be more used for accidental exposures and not for patients looking to eat a particular food allergen ad lib.

Approximately 32 million Americans suffer from food allergies and there are approximately 200,000 ER visits a year for this issue. There are a multitude of other treatments that are being investigated for peanut allergy.  There is the oral immunotherapy, Palforzia, a peanut patch is also being developed too.

Palforzia (formerly AR101) and peanut allergy

Prevention is the most important key to avoid peanut allergy, current guidelines support the early introduction of peanuts in babies.

New Peanut Guidelines

Caregivers are not supporting early peanut introduction guidelines

AR101 a Potential Peanut Allergy Cure

Peanut Allergy Cure?

Peanut Allergy Prevention

 

 

 

Filed Under: biologics, Blog, Food allergy

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

January 22, 2023

Is Benadryl Safe to use, or is it Time to Move on?

is benadryl safe

January 12, 2023

Airsupra for Asthma, a new rescue medication

airsupra

December 26, 2022

Cantaloupe Allergy comes in many flavors

cantaloupe allergy

December 23, 2022

Remibrutinib, a BTK inhibitor for Chronic Hives

remibrutininb

November 21, 2022

Eczema and Hard Water, is there a link?

eczema and hard water

November 19, 2022

Nucala, Fasenra or Dupixent for Severe Eosinophilic Asthma?

nucala fasenra dupixent

November 18, 2022

Xolair for idiopathic angioedema

xolair for idiopathic angioedema

September 29, 2022

When will my child outgrow egg allergy?

outgrow egg allergy

September 13, 2022

Can you be allergic to water? (Aquagenic Urticaria)

allergic to water

September 8, 2022

Oclacitinib for Atopic Dermatitis (Eczema) in Dogs

oclacitinib

Read More Posts...

Follow Us…

© 2023 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page